Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of IV Ferric Carboxymaltose vs Standard Care in CKD Anemia
NCT00548691Phase 3Completed
- Sponsor
- American Regent, Inc.
- Start
- Oct 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by American Regent, Inc.. Started Oct 2007; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT00548691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548691.